HMOs can provide economical outpatient parenteral antibiotic therapy that takes advantage of existing nursing and physician staff as well as centralized pharmacy services. Reimbursement problems are nonexistent. Treatment is possible in the home or clinic. In the model presented, the therapeutic program is initiated and supervised by infectious disease specialists.